You're reading a SIGNA Wire case file. Get alerts like this for free. Sign in · Learn more →
Guardian Drug Co. Inc.FDAMed source confidence · 80%Jun 22, 2026, 6:17 PM UTC · 15d ago

Guardian Drug Co. Inc. — FDA Class II (D-0577-2026)

Case File

Guardian Drug Co. is recalling a human over-the-counter drug due to contamination with small metallic particles. This recall is classified as a Class II recall, indicating a temporary health issue. The specific product affected is identified by NDC 41163-171.

Sign in to follow Guardian Drug Co. Inc. and get alerts like this
Key Points
  • Guardian Drug Co. is recalling a human OTC drug.
  • The product is contaminated with small metallic particles.
  • This is classified as a Class II recall.
  • Consumers should check their medicine cabinets for this product.
  • Contamination recalls like this are typically viewed as serious health risks.
Why This Matters

Consumers who purchased this product should stop using it immediately due to potential health risks from contamination. The recall affects all units of the product identified by NDC 41163-171.

View original filing →
Sign in to follow Guardian Drug Co. Inc. and get alerts like this

SIGNA Wire provides informational summaries of official government filings. Not investment advice.